Gauhati HC Halts Assam Govt’s Pharmacy Regulations

Guwahati: The Gauhati High Court has imposed a temporary stay on the Assam government’s regulations on pharmacy education. These regulations included a mandatory exit exam for pharmacy graduates from private universities and non-affiliated institutions before they could be licensed as pharmacists.

The court’s decision stemmed from a petition filed by Girijananda Chowdhury University.

Gauhati High Court judge Justice N Unni Krishnan Nair, presiding over the case, raised doubts about the Assam government’s authority to regulate the pharmacy profession based on a preliminary review of the Pharmacy Act 1948.

A crucial aspect of the court’s concern was the absence of any mention regarding approval from the Pharmacy Council of India (PCI) in the government notification, which is a mandatory requirement for such regulations.

The High court stayed the Assam government‘s notification outlining regulations for pharmacy education and practice is on hold until the court reaches a final decision.

The court has also postponed the exit exam scheduled for April 21 to assess graduates from private universities and non-affiliated institutions.

The court further said that Pharmacy graduates can register with the Assam Pharmacy Council upon completion of their courses. However, the council will conduct verification to ensure the programs meet the guidelines set by the Pharmacy Council of India.

Students enrolled in Diploma in Pharmacy programs before the 2022-23 academic session can obtain provisional registration after the Assam Pharmacy Council verifies their educational qualifications, the court mentioned in the order.

According to the order, students who entered Diploma in Pharmacy programs during the 2022-23 academic sessions will need to pass the exit exam mandated by the Pharmacy Council of India to become registered pharmacists.

It’s important to note that the court order doesn’t prevent the Pharmacy Council of India from conducting their scheduled exit exam.

The next hearing for this case is scheduled for May 15th, 2024.

The High Court has directed the Assam government to file their response by May 13th.

Related Posts

Cancer cure must not be hostage to Big Pharma

In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients